What Is Juvéderm®?
Juvéderm is an injectable facial filler derived from hyaluronic acid, like Restylane®. Allergan, the manufacturer of Juvéderm, describes it as a “next generation” filler, and it has two significant differences from other hyaluronic acid fillers. Juvéderm is produced with more cross-linking between the hyaluronic acid molecules, which may make them more resistant to absorption by the body, and it is produced with a smoother texture than other hyaluronic acid fillers.
What Does Juvéderm®Treat?
Like other facial fillers, Juvéderm is used to treat nasolabial folds and other skin folds and wrinkles due to a loss of facial volume or skin tone. Like Restylane, it can be a complementary treatment to Botox® injections.
Juvéderm Ultra is designed to target fine lines in the face that are more superficial in nature. This FDA-approved treatment is composed of hyaluronic acid, a natural component of the human body, and often has results that last six months to a year.
Juvéderm® Ultra Plus
Juvéderm Ultra Plus is another member of the Juvéderm family that is designed to rejuvenate the appearance of moderate to severe wrinkles in the face. This injectable gel is more concentrated in its composition, allowing Dr. Friedman to treat deeper facial folds and wrinkles, with results that can often last up to a year.
What Results Can I Expect and How Long Do They Last?
Although individual results may vary, during Juvéderm clinical trials some subjects received correction of nasolabial folds of up to one year. One definite advantage of Juvéderm is that its smooth texture can lead to less irritation following treatment. Whereas most patients receiving Restylane experience swelling and redness for up to three days, swelling and redness following Juvéderm injections is much less and of shorter duration.
Schedule Your Consultation
If you want to learn more about what makes Juvéderm distinct from other facial fillers, schedule a Juvéderm consultation with contact one of our doctors at the Dermatology & Laser Surgery Center today.